Target intelligence / Profile preview

Edema factor (EF)

Target
EF
Molecular classification
Enzyme, Bacterial exotoxin, Adenylyl cyclase toxin
01

Overview

Edema factor is a bacterial exotoxin enzyme secreted by Bacillus anthracis and is a principal virulence factor in anthrax disease. It is an adenylyl cyclase that becomes highly active upon binding to calmodulin inside host cells, converting ATP to cyclic AMP at rates much higher than mammalian enzymes. The resulting surge in cAMP disrupts immune cell function, impairs host defense mechanisms, and causes fluid accumulation (edema), favoring bacterial spread and survival. EF acts synergistically with protective antigen (forming "edema toxin") and is structurally distinct from mammalian adenylyl cyclases, which makes it a plausible therapeutic target for future anti-anthrax strategies[1][5][7].

Other names
Anthrax edema factorBacillus anthracis edema factorEF
02

Mechanism of action

Enzymatic conversion of ATP to cAMP upon activation by host calmodulin, leading to dysregulation of host cell signaling pathways[1][7] Forms part of "edema toxin" when combined with protective antigen (PA)[5] Requires entry into host cells via PA-mediated translocation[5][8]

03

Biological functions

Elevates intracellular cyclic AMP (cAMP) levels in host cellsDisrupts immune cell signalingInhibits phagocyte functionFacilitates bacterial immune evasionContributes to tissue edema
04

Disease associations

Infection (specifically anthrax)Virulence determinant in Bacillus anthracis pathogenesis
05

Safety considerations

Targeting EF must avoid unintended effects on mammalian adenylyl cyclases, though EF has a distinct structure which aids specificity[7]Risk of exacerbating inflammation or immune suppression if not precisely inhibited
06

Interacting drugs

Research-stage small molecule inhibitors targeting the adenylyl cyclase active site (none currently approved)

2 more in the full profile.

07

Biomarkers

Elevated intracellular cAMP in cells exposed to edema toxinPresence of edema toxin or its activity (diagnostic marker in anthrax research, not routinely used in clinics)

Beyond the preview

Go deeper on Edema factor (EF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Edema factor (EF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call